Stages Escrito por el personal de Mayo Clinic After confirming a diagnosis of pancreatic cancer, your healthcare team works to find how much cancer is in the body and how far it has spread. This is called the stage of the cancer. To find the stage of pancreatic cancer, the healthcare team typically uses imaging tests such as CT or MRI scans. Endoscopic ultrasound, biopsy results and other test results may provide more information. The staging system below is used for exocrine pancreatic cancers, including pancreatic ductal adenocarcinoma. Health professionals use a different staging system for pancreatic neuroendocrine tumors. For exocrine pancreatic cancer, stage is based on the tumor's size and whether it involves nearby major blood vessels, as well as whether cancer has spread to nearby lymph nodes or other parts of the body. This is called the TNM system. T stands for tumor, N for lymph nodes and M for cancer that has spread to other parts of the body. The stages of exocrine pancreatic cancer include: Stage 0. Cancer cells are found only in the lining of a pancreatic duct. They have not grown into deeper pancreatic tissue or spread to lymph nodes or other parts of the body. Stage 0 also is called carcinoma in situ. Stage 1. The cancer has grown into the tissue of the pancreas and is no larger than 1.5 inches (4 cm). It has not spread to lymph nodes or other organs. Stage 2. The cancer may be larger than 1.5 inches (4 cm) or it may have spread to some nearby lymph nodes. It has not spread to other organs. Stage 3. Cancer has spread to four or more nearby lymph nodes. Or the cancer has grown into major blood vessels near the pancreas. It has not spread to other organs. Stage 4. Cancer has spread to parts of the body farther away from the pancreas. Common places include the liver, the lungs and the lining of the abdomen, also called the peritoneum. Earlier stages mean the cancer is smaller and more limited. Later stages mean it has spread farther, such as to lymph nodes, major blood vessels or distant organs. Knowing the stage helps the healthcare team plan treatment. Surgery may be an option if the cancer can be removed safely. This depends in part on whether the cancer involves nearby blood vessels or has spread to distant organs. Cancer that has spread to distant organs isn't treated with surgery to remove the pancreas. Solicite una consulta Diagnóstico y tratamiento May 04, 2024 Comparte en: FacebookTwitter Living with cáncer de páncreas? Connect with others like you for support and answers to your questions in the Pancreatic Cancer support group on Mayo Clinic Connect, a patient community. Pancreatic Cancer Discussions Pancreatic Cancer Group: Introduce yourself and connect with others 2410 Replies Mon, Sep 28, 2026 chevron-right Anyone else on Daraxonrasib (RMC-6236)? 150 Replies Mon, Sep 28, 2026 chevron-right Have you ever had hiccups with or after chemotherapy? 134 Replies Sat, Sep 26, 2026 chevron-right See more discussions Mostrar referencias AskMayoExpert. Pancreatic cancer (adult). Mayo Clinic; 2022. Groggins M, et al. Management of patients with increased risk for familial pancreatic cancer: Updated recommendations from the International Cancer of the Pancrease Screening (CAPS) Consortium. Gut. 2020; doi:10.1136/gutjnl- 2019- 319352. Debouk M, et al. The Multicenter Cancer of Pancreas screening study: Impact on stage and survival. Journal of Clinical Oncology. 2022; doi:10.1200/JCO.22.00298. Pancreatic adenocarcinoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455. Accessed April 27, 2023. De la Fuente J, et al. How I approach screening for pancreatic cancer. American Journal of Gastroenterology. 2021; doi:10.14309/ajg.0000000000001305. Fernandez-del Castillo C. Clinical manifestations, diagnosis and staging of exocrine pancreatic cancer. https://www.uptodate.com/contents/search. Accessed April 26, 2023. Pancreatic cancer treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/pancreatic/hp/pancreatic-treatment-pdq. Accessed April 26, 2023. Distress management. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455 Accessed April 27, 2023. Ryan DP. Initial systemic chemotherapy for metastatic exocrine pancreatic cancer. https://www.uptodate.com/contents/search. Accessed April 26, 2023. AskMayoExpert. Pancreas ductal adenocarcinoma: Diagnosis and treatment (adult). Mayo Clinic; 2022. Fernandez-del Castillo C, et al. Overview of surgery in the treatment of exocrine pancreatic cancer and prognosis. https://www.uptodate.com/contents/search. Accessed April 26, 2023. NPF Centers of Excellence. National Pancreas Foundation. https://pancreasfoundation.org/patient-resources/npf-centers-of-excellence/. Accessed April 27, 2023. Niederhuber JE, et al., eds. Carcinoma of the pancreas. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. http://www.clinicalkey.com. Accessed April 28, 2023. Sugumar A, et al. Distinguishing pancreatic cancer from autoimmune pancreatitis. Current Gastroenterology Reports. 2010;12:91. Ami T. Allscripts EPSi. Mayo Clinic. Feb. 28, 2022. Pancreatic Cancer Genetic Epidemiology (PACGENE) Study. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00526578. Accessed April 26, 2023. Thind K et al. Immunotherapy in pancreatic cancer treatment: A new frontier. Therapeutic Advances in Gastroenterology. 2017;10:168. Tee MC, et al. Laparoscopic pancreaticoduodenectomy: Is it an effective procedure for pancreatic ductal adenocarcinoma? Advances in Surgery. 2015;49:143. Merrell KW, et al. Predictors of locoregional failure and impact on overall survival in patients with resected exocrine pancreatic cancer. International Journal of Radiation Oncology. 2016;doi:10.1016/j.ijrobp.2015.11.003. Moris M, et al. Risk factors for malignant progression of intraductal papillary mucinous neoplasms. Digestive and Liver Disease. 2015;47:495. Pancreatic cancer: Symptoms and signs. Cancer.Net. https://www.cancer.net/cancer-types/pancreatic-cancer/symtpms-and-signs. Accessed May 2, 2023. Loncle C, et al. The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes KRAS-G12D-mediated pancreatic cancer initiation. Cell Death and Disease. 2016;7:32295. Thiels CA, et al. Outcomes of pancreaticoduodenectomy for pancreatic neuroendocrine tumors: Are combined procedures justified? Journal of Gastrointestinal Surgery. 2016;20:891. Cáncer de páncreasSíntomas&causasDiagnósticoytratamientoMédicosydepartamentosAtención médicaenMayo Clinic CON-20248520 Enfermedades y afecciones Cáncer de páncreas